Valuation: Yuhan Corporation

Market Cap 5,529B 4.11B 3.65B 3.4B 3.1B 5.85B 395B 5.91B 41.2B 15.97B 202B 15.41B 15.08B 648B P/E 2026 *
35.4x
P/E 2027 * 27.2x
Enterprise Value 5.44B 4.04M 3.59M 3.35M 3.05M 5.76M 388M 5.81M 40.53M 15.71M 198M 15.16M 14.84M 637M EV / Sales 2026 *
2.32x
EV / Sales 2027 * 2.12x
Free-Float
61.43%
Yield 2026 *
0.78%
Yield 2027 * 0.78%
1 day-0.94%
Current month+1.79%
1 month-10.40%
3 months+5.11%
6 months-25.53%
Current year-34.07%
1 week 72,000
Extreme 72000
75,500
1 month 72,000
Extreme 72000
84,700
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%0.00%-38.15%+2.65% 4.09B
-0.61%-3.30%+38.46%+112.77% 1,025B
-1.02%-5.41%+37.61%+64.39% 623B
+1.11%-0.87%+7.55%+76.32% 459B
+0.34%-2.49%+60.10%+40.17% 355B
-0.95%-4.87%+22.46%+38.03% 336B
-1.46%-2.20%+11.84%+23.94% 270B
-1.35%-4.27%-4.55%+6.92% 247B
-1.04%-0.74%+35.02%+49.96% 220B
-1.87%-3.31%+30.22%+93.14% 183B
Average -0.31%-1.78%+20.06%+50.83% 372.23B
Weighted average by Cap. +0.42%-2.11%+29.65%+68.24%

Financials

2026 *2027 *
Net sales 2,342B 1.74B 1.55B 1.44B 1.31B 2.48B 167B 2.5B 17.45B 6.76B 85.46B 6.53B 6.39B 274B 2,548B 1.89B 1.68B 1.57B 1.43B 2.7B 182B 2.72B 18.99B 7.36B 92.99B 7.1B 6.95B 298B
Net income 160B 119M 106M 98.58M 89.85M 169M 11.43B 171M 1.19B 462M 5.84B 446M 437M 18.75B 201B 149M 133M 124M 113M 213M 14.37B 215M 1.5B 581M 7.35B 561M 549M 23.57B
Net Debt -89.35B -66.35M -58.95M -55.02M -50.15M -94.58M -6.38B -95.46M -666M -258M -3.26B -249M -244M -10.46B -133B -98.63M -87.63M -81.79M -74.55M -141M -9.48B -142M -990M -384M -4.85B -370M -362M -15.56B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,082
Date Price Change Volume
26-10-02 ₩74,100.00 -0.94% 120,454
26-10-01 ₩74,800.00 +2.75% 155,768
26-09-30 ₩72,800.00 -0.27% 178,802
26-09-29 ₩73,000.00 -2.28% 202,345
26-09-28 ₩74,700.00 +0.81% 192,739
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
74,100.00KRW
Average target price
113,941.18KRW
Spread / Average Target
+53.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock